1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
- 2021
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Proteomic data analysis for differential profiling of the autoimmune diseases SLE, RA, SS, and ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
- 2020
-
Mark
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
(
- Contribution to journal › Published meeting abstract
-
Mark
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
(
- Contribution to journal › Published meeting abstract